Impaired Renal Function Clinical Trial
Official title:
A Phase I, Open Label, Multicenter, Parallel-group, Single Dose Two-staged Study to Evaluate the Pharmacokinetics and Safety of a Single 400 mg Oral Dose of LEE011 in Subjects With Varying Degrees of Impaired Renal Function Compared to Matched Healthy Volunteers With Normal Renal Function
The purpose of this study is to characterize the PK and safety profile of LEE011 following a single oral dose in adult subjects with various degrees of renal impairment compared to a matched group of healthy subjects with normal renal function.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04252430 -
RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01716455 -
Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function
|
Phase 1 | |
| Completed |
NCT02087566 -
Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)
|
N/A | |
| Completed |
NCT04179630 -
Study of Aldafermin (NGM282) in Participants With Impaired Renal Function
|
Phase 1 | |
| Completed |
NCT00779922 -
Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
|
Phase 2 | |
| Completed |
NCT00784381 -
Computer Prescribing System and Impaired Renal Function
|
Phase 3 | |
| Completed |
NCT01507350 -
Effects of Obesity Surgery on Renal Function
|
||
| Active, not recruiting |
NCT01760031 -
Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy
|
N/A | |
| Completed |
NCT03776539 -
A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
|
Phase 1 | |
| Completed |
NCT01035320 -
Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment
|
Phase 4 | |
| Completed |
NCT00604357 -
CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment
|
Phase 3 | |
| Completed |
NCT02965040 -
A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function
|
Phase 1 | |
| Completed |
NCT00981045 -
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
|
Phase 3 | |
| Completed |
NCT02467478 -
Linagliptin's Effect on CD34+ Stem Cells
|
Phase 4 | |
| Recruiting |
NCT04620590 -
An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function
|
Phase 4 |